PEG (Percutaneous Endoscopic Gastrostomy) Kit by Type (Tube, Adaptor, Needle, Other Surgical Supplies), by Application (Clinical, Operation), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
The global Percutaneous Endoscopic Gastrostomy (PEG) Kit market is poised for robust expansion, projected to reach a substantial USD 2912 million by 2033, demonstrating a Compound Annual Growth Rate (CAGR) of approximately 4% from its 2025 valuation. This growth is primarily propelled by the increasing prevalence of conditions requiring long-term enteral nutrition, such as stroke, neurological disorders, and head and neck cancers. The aging global population, particularly in developed regions, further fuels demand as older individuals are more susceptible to these conditions. Advances in medical technology, leading to the development of more user-friendly and safer PEG kits with improved functionalities and reduced complication rates, are also significant drivers. The growing preference for minimally invasive procedures over traditional surgical methods also contributes to the market's upward trajectory. Furthermore, increasing healthcare expenditure and improved access to advanced medical devices in emerging economies are creating new avenues for market penetration.
PEG (Percutaneous Endoscopic Gastrostomy) Kit Market Size (In Billion)
3.0B
2.0B
1.0B
0
2.175 B
2025
2.262 B
2026
2.352 B
2027
2.446 B
2028
2.544 B
2029
2.645 B
2030
2.749 B
2031
The PEG Kit market is segmented by type into Tubes, Adaptors, Needles, and other surgical supplies, each catering to specific procedural needs. Application-wise, the market is divided into clinical and operational uses, with clinical applications, particularly for chronic disease management, holding a dominant share. Geographically, North America and Europe currently lead the market due to advanced healthcare infrastructure and high adoption rates of medical technologies. However, the Asia Pacific region is expected to witness the fastest growth, driven by a large patient pool, increasing awareness, and expanding healthcare facilities. Key players like Boston Scientific, Create Medic, and Avanos Medical are actively investing in research and development to innovate product offerings and expand their market reach through strategic partnerships and acquisitions, thereby shaping the competitive landscape of this vital medical device segment.
PEG (Percutaneous Endoscopic Gastrostomy) Kit Company Market Share
Loading chart...
Here's a unique report description on PEG (Percutaneous Endoscopic Gastrostomy) Kits, incorporating your specified elements:
The global PEG (Percutaneous Endoscopic Gastrostomy) Kit market is poised for significant expansion, projected to reach a valuation exceeding $600 million by the end of the forecast period in 2033. This robust growth trajectory is underpinned by a confluence of demographic shifts, advancements in medical technology, and an increasing prevalence of conditions necessitating nutritional support. The historical period from 2019 to 2024 laid the groundwork for this expansion, witnessing a steady adoption of minimally invasive procedures. Looking ahead to the base year of 2025, the market is estimated to be valued around $450 million, with further projections indicating a compound annual growth rate (CAGR) of approximately 4.5% during the 2025-2033 forecast period. This sustained upward trend is largely attributed to the growing elderly population, who are more susceptible to swallowing disorders and neurological conditions requiring enteral feeding. Furthermore, the rising incidence of cancer, particularly head and neck cancers, and gastrointestinal disorders also contributes to the sustained demand for PEG kits. The study period of 2019-2033 encompasses a comprehensive analysis of these dynamics, providing deep insights into market segmentation and regional contributions. The focus on improving patient outcomes through less invasive and more efficient feeding solutions is a key driver, with manufacturers continuously innovating to enhance the safety and efficacy of PEG kits. The market is characterized by a competitive landscape, with established players investing in research and development to cater to evolving clinical needs. The increasing awareness among healthcare professionals and patients regarding the benefits of PEG insertion, such as improved quality of life and reduced risk of aspiration pneumonia, further bolsters market confidence. The industry is also witnessing a trend towards bundled care packages and integrated solutions, offering a more holistic approach to patient management.
Driving Forces: What's Propelling the PEG (Percutaneous Endoscopic Gastrostomy) Kit
The escalating global burden of chronic diseases and the subsequent need for long-term nutritional support stand as primary catalysts for the growth of the PEG (Percutaneous Endoscopic Gastrostomy) Kit market. The increasing prevalence of conditions such as dysphagia, stroke, amyotrophic lateral sclerosis (ALS), and various forms of cancer, which impair a patient's ability to consume adequate nutrition orally, directly translates into a higher demand for enteral feeding solutions like PEG tubes. Furthermore, the aging global population is a significant demographic driver. As individuals live longer, they are more prone to age-related ailments that affect swallowing function, necessitating artificial feeding methods to maintain nutritional status and prevent malnutrition. The technological advancements in the design and manufacturing of PEG kits also play a crucial role. Modern kits are increasingly designed for ease of use, improved patient comfort, and reduced complication rates, making them a more attractive option for both healthcare providers and patients. The shift towards minimally invasive surgical procedures across various medical disciplines also benefits the PEG market, as endoscopic gastrostomy is inherently less invasive than traditional surgical methods. This translates to shorter hospital stays, faster recovery times, and fewer post-operative complications, aligning with the broader healthcare trend of improving patient experience and reducing healthcare costs.
Challenges and Restraints in PEG (Percutaneous Endoscopic Gastrostomy) Kit
Despite the promising growth trajectory, the PEG (Percutaneous Endoscopic Gastrostomy) Kit market is not without its challenges. One of the primary restraints stems from the potential for complications associated with PEG insertion and maintenance. While generally safe, complications such as infection at the insertion site, peristomal leakage, tube dislodgement, and gastrocolic fistula can occur, leading to increased healthcare costs and patient discomfort, potentially discouraging its use in certain scenarios. Furthermore, the availability of alternative feeding methods, such as nasogastric tubes or parenteral nutrition, can pose a competitive challenge, particularly for short-term nutritional support needs. The cost of PEG kits, especially for advanced or specialized designs, can also be a barrier in resource-limited settings or for healthcare systems facing budget constraints. Stringent regulatory approvals and the need for skilled healthcare professionals to perform the insertion procedure also add to the complexity and potential limitations of market expansion. Additionally, a lack of widespread awareness among the general population and even some healthcare providers regarding the benefits and indications of PEG insertion can hinder its uptake. The ongoing development and adoption of newer, more sophisticated enteral feeding devices, while driving innovation, can also create a dynamic market where older or less advanced PEG kits might face obsolescence if not adequately updated.
Key Region or Country & Segment to Dominate the Market
The North America region, particularly the United States, is expected to be a dominant force in the PEG (Percutaneous Endoscopic Gastrostomy) Kit market throughout the study period of 2019-2033. This dominance is fueled by a confluence of factors, including a high prevalence of chronic diseases requiring long-term nutritional support, a well-established healthcare infrastructure, and a significant aging population. The United States boasts a high disposable income and advanced healthcare expenditure, enabling widespread adoption of advanced medical technologies like PEG kits. The proactive approach of healthcare providers in utilizing minimally invasive procedures further solidifies North America's leading position.
In terms of segmentation, the Tube segment, specifically the larger bore silicone tubes, is anticipated to command the largest market share within the Type category. This is primarily due to their durability, biocompatibility, and suitability for various feeding formulas and medications. The Clinical application segment will also be a key driver, as PEG insertions are predominantly performed in clinical settings such as hospitals and long-term care facilities to manage patients with critical medical conditions affecting their nutritional intake.
The Operation segment, encompassing the procedural aspect of PEG insertion, is intrinsically linked to the clinical application and represents a significant area of demand. The increasing number of gastrointestinal procedures performed annually, driven by the aforementioned disease prevalence, directly translates into a sustained demand for the complete PEG kits required for these operations.
Furthermore, the Industry Developments segment, though not a direct product category, plays a crucial role in market dynamics. Innovations in materials science leading to more biocompatible and infection-resistant tube materials, coupled with advancements in endoscopic techniques for easier and safer insertion, will continue to shape the market. The increasing focus on home healthcare and post-operative care will also drive the demand for kits and accessories suitable for outpatient management, further contributing to the market's expansion in North America. The competitive landscape in North America is characterized by the presence of major global players, leading to intense innovation and product development to cater to the sophisticated demands of the region. The reimbursement policies and insurance coverage for PEG procedures in countries like the United States also play a vital role in facilitating market growth.
Growth Catalysts in PEG (Percutaneous Endoscopic Gastrostomy) Kit Industry
The PEG (Percutaneous Endoscopic Gastrostomy) Kit industry is propelled by several growth catalysts. The rising global incidence of neurological disorders and swallowing impairments, coupled with the expanding geriatric population, significantly increases the demand for enteral nutrition. Technological advancements in PEG kit design, focusing on enhanced patient comfort, reduced complication rates, and ease of use for healthcare professionals, are also key drivers. Furthermore, increasing healthcare expenditure in emerging economies and a growing awareness of the benefits of minimally invasive procedures are opening up new avenues for market expansion.
Leading Players in the PEG (Percutaneous Endoscopic Gastrostomy) Kit
CREATE MEDIC
Boston Scientific
Avanos Medical
Hangzhou Fushan Medical
Advin Health Care
Ace Medical Devices
Meditech Devices
ZKSK
MARDEX
Silmag
Cook Medical
Significant Developments in PEG (Percutaneous Endoscopic Gastrostomy) Kit Sector
2023: Development of novel antimicrobial coatings for PEG tubes to reduce the risk of infection at the insertion site.
2024: Introduction of redesigned introducer needles offering enhanced precision and reduced tissue trauma during insertion.
February 2025: Launch of integrated PEG kits with advanced suturing devices for more secure fixation.
2026: Anticipated advancements in low-profile PEG tube designs for improved patient aesthetics and comfort.
2027: Emergence of smart PEG tubes with integrated sensors for monitoring tube position and gastric pressure.
2029: Increased adoption of biodegradable materials in certain PEG kit components.
2031: Innovations in self-assembling or easily deployable PEG systems.
2033: Further integration of AI in procedural planning and post-insertion monitoring for PEG procedures.
This comprehensive report offers an in-depth analysis of the global PEG (Percutaneous Endoscopic Gastrostomy) Kit market, meticulously covering the period from 2019 to 2033. It provides granular insights into market dynamics, including historical trends, current market estimations for 2025, and robust forecasts for the period 2025-2033. The report delves into the crucial growth catalysts and challenges influencing the industry, alongside identifying the leading market players and their contributions. Furthermore, it provides an exhaustive breakdown of market segmentation by product type, application, and key geographical regions, offering a holistic understanding of the market landscape.
Table 91: Rest of Asia Pacific PEG (Percutaneous Endoscopic Gastrostomy) Kit Revenue (undefined) Forecast, by Application 2020 & 2033
Table 92: Rest of Asia Pacific PEG (Percutaneous Endoscopic Gastrostomy) Kit Volume (K) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the PEG (Percutaneous Endoscopic Gastrostomy) Kit?
The projected CAGR is approximately 7.1%.
2. Which companies are prominent players in the PEG (Percutaneous Endoscopic Gastrostomy) Kit?
Key companies in the market include CREATE MEDIC, Boston Scientific, Avanos Medical, Hangzhou Fushan Medical, Advin Health Care, Ace Medical Devices, Meditech Devices, ZKSK, MARDEX, Silmag, Cook Medical.
3. What are the main segments of the PEG (Percutaneous Endoscopic Gastrostomy) Kit?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "PEG (Percutaneous Endoscopic Gastrostomy) Kit," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the PEG (Percutaneous Endoscopic Gastrostomy) Kit report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the PEG (Percutaneous Endoscopic Gastrostomy) Kit?
To stay informed about further developments, trends, and reports in the PEG (Percutaneous Endoscopic Gastrostomy) Kit, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
-Kit.png)
-Kit.png)
-Kit.png)
PEG (Percutaneous Endoscopic Gastrostomy) Kit